Login / Signup

Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study.

Johannes Steffen KernEli SprecherMaria Florencia FernandezFranziska SchauerChristine BodemerTracy CunninghamSandra LöweCharles DavisMark SumerayAnna L BrucknerDedee Frances Murrellnull null
Published in: The British journal of dermatology (2023)
Oleogel-S10 is the first therapy to demonstrate accelerated wound healing in EB. Oleogel-S10 was well -tolerated.
Keyphrases
  • phase iii
  • double blind
  • placebo controlled
  • open label
  • clinical trial
  • phase ii
  • wound healing
  • study protocol
  • randomized controlled trial
  • mesenchymal stem cells
  • cell therapy
  • stem cells
  • smoking cessation